For decades, Pittsburgh's economy was directly tied to one industry: steel. But now, a new identity is taking shape. Investments in education and innovation-friendly policies have launched a growing technology and startup community. Uber, Facebook, Google and a number of other tech giants have planted their flags in the Steel City.
But despite this, Pittsburgh has had slow job growth since the recession, and many say that the economic benefits of the city’s urban revival have not reached its neighboring communities. How can Pittsburgh ensure that everyone has the tools to compete in the city’s 21st century economy?
The Atlantic gathered city officials and local industry and community leaders for a robust discussion about Pittsburgh's comeback and efforts to create opportunity for all who call it home.
Watch the full event
- Wednesday, May 17
- 5:30 p.m.Guest Arrival and Reception -
- 6:05 p.m.WelcomeMargaret Low, President, AtlanticLIVE
Chris Redd, Territory Sales Leader, Allstate
Stacy Drumtra, Director, CEO Strategic Communications, Allstate Insurance Company
- 6:15 p.m.InterviewMayor Bill Peduto, City of Pittsburgh
With Ron Brownstein, Senior Editor, The Atlantic
- 6:40 p.m.Panel DiscussionPresley Gillespie, President, Neighborhood Allies
Kevin McMahon, President and CEO, Pittsburgh Cultural Trust
Andrew Moore, Dean, School of Computer Science, Carnegie Mellon University
Stefani Pashman, CEO, Partner4Work
With Ron Brownstein, The Atlantic
- 7:15 p.m.Closing Thoughts Margaret Low, AtlanticLIVE
Also in This Series
Featuring Graham Allison
and Jeffrey Goldberg
Graham Allison, Director of Harvard University's Belfer Center for Science and International Affairs, and author of Destined for War: Can America and China Escape Thucydides’s Trap?, will join The Atlantic’s Editor in Chief Jeffrey Goldberg to explore the US-China relationship and see how war in East Asia can be avoided.
The Next Drugs:
An Atlantic Policy Update on Biosimilars
The Atlantic will convene key stakeholders to discuss the state of and future for biosimilars.